Ubiquitin probes are specialized molecular tools that enable the detection, quantification, and mechanistic study of ubiquitin-modifying and ubiquitin-processing enzymes. They encompass a diverse array of chemical architectures including activity-based probes (ABPs), fluorogenic substrates, affinity probes, crosslinking probes, and photo-activatable reagents. Together, these tools have transformed our understanding of the ubiquitin-proteasome system (UPS) and the broader ubiquitin code, enabling breakthroughs in enzymology, structural biology, cell biology, and drug discovery.
1. Introduction to the Ubiquitin System
Ubiquitin is a 76-amino acid protein with a molecular weight of approximately 8.6 kDa that is expressed in virtually all eukaryotic cells and is among the most conserved proteins in nature. Its primary sequence differs by only three amino acids between yeast and humans, underscoring its fundamental biological importance. Ubiquitin is covalently attached to substrate proteins through a highly regulated, three-enzyme cascade involving E1 ubiquitin-activating enzymes, E2 ubiquitin-conjugating enzymes, and E3 ubiquitin ligases. The resulting isopeptide bond between the C-terminal glycine (Gly76) of ubiquitin and a lysine residue on the target protein constitutes the post-translational modification known as ubiquitination.
The consequences of ubiquitination are remarkably diverse and depend critically on the type of ubiquitin modification. Monoubiquitination regulates processes such as histone function, DNA damage response, receptor endocytosis, and virus budding. Polyubiquitin chains, formed by linking successive ubiquitin molecules through any of the seven internal lysines (K6, K11, K27, K29, K33, K48, K63) or the N-terminal methionine (M1, linear chains), encode distinct cellular signals. K48-linked chains are the canonical signal for proteasomal degradation, while K63-linked chains participate in DNA repair, autophagy, and NF-κB signaling. Other chain types (K6, K11, K29, K33, M1) and branched or mixed chains have emerged as important regulators of immune signaling, mitophagy, and cell cycle control.
Reversal of ubiquitination is accomplished by a family of approximately 100 deubiquitylating enzymes (DUBs) in the human proteome, classified into seven subfamilies: ubiquitin C-terminal hydrolases (UCH), ubiquitin-specific proteases (USP), ovarian tumor domain proteases (OTU), Machado-Joseph disease domain proteases (MJD/Josephin), MINDY (motif interacting with Ub-containing novel DUB family), ZUFSP, and the JAB1/MPN/MOV34 (JAMM) metalloproteases. The fine-tuned interplay between ubiquitin writers (E1-E2-E3 cascade), erasers (DUBs), and readers (ubiquitin-binding domain proteins) constitutes the “ubiquitin code” — a complex post-translational signaling language that governs virtually every aspect of eukaryotic cell biology.
Understanding this intricate system has required the development of highly specialized molecular tools: ubiquitin probes. These reagents, which range from simple fluorogenic substrates to sophisticated bifunctional chemical probes, have been instrumental in deciphering the biochemical and cellular logic of ubiquitin signaling and have provided the foundation for a rapidly growing field of ubiquitin-targeted drug discovery.
2. Classification of Ubiquitin Probes
• Activity-Based Probes (ABPs): Covalent or mechanism-based probes that react selectively with the active site of ubiquitin-processing enzymes.
• Fluorogenic Substrates: Probes that generate a fluorescent signal upon enzymatic cleavage, used for activity measurement and high-throughput screening.
• Affinity and Pull-Down Probes: Probes designed to enrich ubiquitin-modified proteins or ubiquitin-interacting proteins from complex biological mixtures.
• Crosslinking Probes: Probes that form covalent crosslinks between ubiquitin and interacting proteins, used to capture transient or weak interactions.
• Photo-Activatable Probes: Probes incorporating photo-reactive groups that form covalent bonds upon UV irradiation, enabling spatial and temporal control.
• Diubiquitin and Polyubiquitin Probes: Probes based on defined ubiquitin chain topologies, used to study linkage-selective enzymes and readers.
• Ubiquitin Variants (UbVs) and Designed Ubiquitin Proteins: Engineered ubiquitin proteins with altered binding specificity, used as selective inhibitors or interactors.
• Isotope-Labeled Ubiquitin Probes: Stable isotope-labeled ubiquitin for quantitative proteomics (SILAC, TMT) and NMR structural studies.
3. Activity-Based Probes (ABPs)
3.1 Principles of Activity-Based Protein Profiling
Activity-based protein profiling (ABPP) is a chemical biology strategy that employs reactive small molecules — activity-based probes — to covalently label the active sites of enzyme families in a mechanism-dependent manner. ABPs consist of three functional modules: (1) a reactive group (warhead) that reacts selectively with a catalytic residue; (2) a recognition element (ubiquitin or ubiquitin-like sequence) that directs the probe to the target enzyme’s active site; and (3) a reporter tag (fluorophore, biotin, or alkyne handle for click chemistry) that enables detection, enrichment, or visualization of labeled enzymes.
For DUBs and other ubiquitin-processing enzymes, the recognition element is most commonly ubiquitin itself, which occupies the enzyme active site in the same way as the natural substrate. This ensures high selectivity and physiological relevance of the probe-enzyme interaction. The warhead is placed at the C-terminus of ubiquitin (adjacent to the cleavage site at Gly76) and reacts with the active-site nucleophile (typically a cysteine residue in cysteine DUBs or a zinc-coordinated water molecule in metalloprotease DUBs) to form a stable, irreversible covalent adduct.
3.2 Electrophilic Warhead Classes
The choice of warhead determines the chemical reactivity, selectivity, and breadth of DUB classes targeted by an ABP. The most widely used warhead types are:
3.2.1 Vinyl Sulfone (VS)
Vinyl sulfone is a Michael acceptor warhead that reacts with cysteine DUBs through a thiol-Michael addition mechanism. Ubiquitin-vinyl sulfone (Ub-VS) was one of the first DUB ABPs to be developed and remains widely used. It reacts with all cysteine DUB families (UCH, USP, OTU, MJD, MINDY, ZUFSP) and does not react with JAMM metalloproteases. The probe forms a stable thioether bond with the active-site cysteine, providing a permanent covalent label suitable for proteomic identification by mass spectrometry or in-gel fluorescence detection. Ub-VS probes are commercially available with C-terminal tags including fluorescein, TAMRA, biotin, or HA epitopes.
3.2.2 Propargylamine (PA)
Propargylamine-based warheads react with cysteine DUBs through a mechanism involving formation of a vinyl thioether intermediate, resulting in a stable and irreversible covalent adduct. Ubiquitin-propargylamine (Ub-PA) probes are among the most broadly reactive DUB ABPs, showing activity against all cysteine DUB families. The alkyne handle incorporated in the propargylamine warhead allows for copper-catalyzed azide-alkyne cycloaddition (CuAAC, “click chemistry”) with azide-functionalized reporter tags, enabling flexible labeling strategies. Ub-PA probes have been extensively used for proteome-wide DUB profiling experiments.
3.2.3 Dehydroalanine (Dha)
Dehydroalanine is an electrophilic amino acid that reacts with cysteine DUBs via conjugate addition. Ub-Dha probes react more slowly than VS or PA probes but with comparable selectivity. Their moderate reactivity can be advantageous for capturing DUBs with lower intrinsic reactivity or for use in competitive labeling experiments where probe reactivity must be balanced against endogenous substrate competition.
3.2.4 Chloroethylamine and Halomethyl Ketone (HMK)
Halomethyl ketone warheads react with cysteine DUBs through alkylation of the active-site thiol. While highly reactive, they can show some non-selectivity and are less commonly used in modern ABP applications. They retain historical significance as some of the earliest DUB inhibitory warheads described.
3.2.5 Acrylamide and Cyanoacrylamide
Acrylamide-based warheads, including cyanoacrylamides, have emerged as reversible covalent warheads that can engage cysteine DUBs in a time-dependent but potentially reversible manner. These warheads are increasingly incorporated into DUB inhibitor programs rather than probe applications, but their incorporation into ubiquitin-based scaffolds has been explored for selective covalent labeling.
3.2.6 Photoactivatable Warheads (Diazirine, Benzophenone)
Diazirine and benzophenone groups generate highly reactive carbene or diradical species upon UV irradiation, forming covalent crosslinks with nearby residues regardless of amino acid identity. When incorporated into ubiquitin probes, these groups enable capture of transient DUB-ubiquitin encounters and mapping of protein-protein interfaces by mass spectrometry.
Warhead: Vinyl sulfone (VS)
Mechanism: Michael addition to Cys
DUB Families Targeted: UCH, USP, OTU, MJD, MINDY, ZUFSP
Reversibility: Irreversible
Common Applications: ABPP, proteomics, gel-based profiling
Warhead: Propargylamine (PA)
Mechanism: Vinyl thioether formation
DUB Families Targeted: UCH, USP, OTU, MJD, MINDY, ZUFSP
Reversibility: Irreversible
Common Applications: ABPP, click chemistry, proteomics
Warhead: Dehydroalanine (Dha)
Mechanism: Conjugate addition to Cys
DUB Families Targeted: UCH, USP, OTU
Reversibility: Irreversible
Common Applications: Competitive ABPP
Warhead: Halomethyl ketone
Mechanism: Alkylation of Cys
DUB Families Targeted: UCH, USP
Reversibility: Irreversible
Common Applications: Historical, inhibitor studies
Warhead: Acrylamide/Cyanoacrylamide
Mechanism: Reversible Michael addition
DUB Families Targeted: Cysteine DUBs
Reversibility: Reversible covalent
Common Applications: Inhibitor programs, labeling
Warhead: Diazirine/Benzophenone
Mechanism: Photo-crosslinking
DUB Families Targeted: Broad (non-selective)
Reversibility: Irreversible
Common Applications: Interactome mapping, interface studies
3.3 Reporter Tags in Ubiquitin ABPs
The reporter tag determines how labeled enzymes are detected, enriched, or visualized. Common reporter tags used in ubiquitin ABPs include:
• Fluorophores (fluorescein, TAMRA, Cy3, Cy5, Rhodamine B): Enable direct in-gel fluorescence detection of labeled DUBs after SDS-PAGE separation. Particularly useful for rapid assessment of DUB reactivity and for competitive ABPP experiments.
• Biotin: Enables streptavidin-based affinity enrichment of labeled enzymes from complex proteomes, followed by identification by mass spectrometry. Biotinylated Ub-VS and Ub-PA are widely used for proteome-wide DUB profiling.
• Alkyne handle (for click chemistry): An alkyne-functionalized probe reacts with azide-tagged reporters (biotin-azide, fluorophore-azide) via CuAAC after labeling. This two-step approach minimizes steric interference during the labeling reaction and maximizes probe penetration in intact cells.
• Epitope tags (HA, FLAG, His6): Facilitate immunoprecipitation-based enrichment and immunoblot detection of labeled enzymes. Particularly useful in cell-based and in vivo experiments.
• Bioorthogonal handles (tetrazine, strained alkene): Emerging reporter strategies using inverse electron demand Diels-Alder reactions for fast, bioorthogonal conjugation in living systems.
3.4 Cell-Permeable Ubiquitin ABPs
A significant challenge in ubiquitin ABP development has been achieving cell permeability. The large size of ubiquitin (8.6 kDa) and its hydrophilic surface make passive membrane diffusion extremely unlikely. Several strategies have been developed to address this:
• Microinjection and electroporation: Physical delivery methods that bypass the membrane barrier, enabling direct introduction of ABPs into living cells.
• Cell-penetrating peptide (CPP) conjugation: Fusion of cationic peptides (e.g., TAT, penetratin) or lipidated sequences to ubiquitin ABPs to facilitate endosomal uptake and cytosolic delivery.
• Protein transduction domains: Fusion of ubiquitin probes with protein transduction domain sequences that promote macropinocytosis-mediated uptake.
• Minimized ubiquitin mimetics: Truncated or peptidomimetic versions of the ubiquitin C-terminal tail carrying the warhead, offering reduced size and potentially improved cell penetration at the expense of full ubiquitin-binding selectivity.
Despite these advances, cell-permeable ubiquitin ABPs remain technically challenging, and most ABPP experiments are still performed in cell lysates rather than intact cells. The development of robust, broadly cell-permeable ubiquitin probes remains an active area of research.
4. Fluorogenic Ubiquitin Substrates
4.1 Ubiquitin-AMC (Ub-AMC)
Ubiquitin-7-amino-4-methylcoumarin (Ub-AMC) was the first widely adopted fluorogenic DUB substrate. 7-amino-4-methylcoumarin (AMC) has excitation and emission maxima at approximately 350 nm and 440 nm, respectively. When coupled to the C-terminus of ubiquitin via an amide bond, the AMC fluorescence is substantially quenched. DUB-mediated hydrolysis releases free AMC, producing a large increase in fluorescence signal.
Ub-AMC has been used extensively for kinetic characterization of DUBs, determination of Michaelis-Menten parameters, and initial screening of DUB inhibitors. However, its UV excitation range (350 nm) is problematic for HTS applications using compound libraries, as many small molecules absorb or fluoresce in this region, causing compound interference and false-positive or false-negative results. Despite this limitation, Ub-AMC remains widely used in academic research settings due to its availability, low cost, and extensive literature validation.
4.2 Ubiquitin-Rhodamine 110 (Ub-Rho110)
Ubiquitin-Rhodamine 110 (Ub-Rho110) represents a major advancement over Ub-AMC for DUB fluorogenic substrate applications. Rhodamine 110 has excitation and emission maxima at 496 nm and 520 nm, respectively, placing the readout in the visible range and dramatically reducing compound interference from library screening. The free amine groups of Rhodamine 110 are required for full fluorescence; amide bond formation at these positions effectively quenches the dye. DUB-mediated cleavage of the Ub-Rho110 amide bond releases free Rhodamine 110, generating a fluorescence enhancement of 100- to >1000-fold over background.
Ub-Rho110 offers superior signal-to-noise ratio, excellent HTS compatibility (Z’ > 0.6 routinely achieved), and broad activity across all DUB families. It has become the preferred substrate for HTS campaigns and is available in 96-, 384-, and 1536-well assay formats. Detailed kinetic characterization of numerous DUBs has been performed using Ub-Rho110, and the substrate has been central to the discovery of several DUB inhibitor classes now in clinical development.
4.3 Ubiquitin-TAMRA and Other Rhodamine Conjugates
TAMRA (tetramethylrhodamine) conjugates of ubiquitin offer distinct spectral properties (Ex/Em ~541/568 nm) useful for multiplexed assays or in combination with other fluorophores. Ub-TAMRA is also used in fluorescence polarization (FP) and fluorescence anisotropy assays to study ubiquitin-protein binding interactions, where the change in molecular tumbling rate upon complex formation provides a readout of binding affinity without requiring enzymatic activity.
4.4 FRET-Based Ubiquitin Probes
Fluorescence resonance energy transfer (FRET)-based ubiquitin substrates incorporate a donor fluorophore and an acceptor fluorophore (or quencher) within the same molecular architecture. In the intact probe, energy transfer from donor to acceptor quenches donor fluorescence. DUB-mediated cleavage separates the fluorophores, eliminating FRET and restoring donor fluorescence. This format is particularly well suited for time-resolved FRET (TR-FRET) measurements, which use lanthanide chelate donors and long fluorescence lifetimes to eliminate short-lived compound autofluorescence, dramatically improving assay quality in HTS settings.
Common FRET pair designs for ubiquitin substrates include Eu-cryptate / d2 (HTRF format), Tb / green fluorophore, and terbium / Alexa Fluor combinations. FRET-based DUB substrates are increasingly available commercially and are preferred for HTS in pharmaceutical and biotech settings due to their superior assay quality and reduced compound interference.
4.5 Luminescence-Based and AlphaScreen Ubiquitin Assays
AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology uses donor and acceptor beads coated with complementary binding partners. In the context of DUB assays, ubiquitin and a substrate protein are each conjugated to one bead type; DUB-mediated deubiquitination separates the beads and reduces luminescence signal. While less commonly used than fluorogenic substrates for kinetic studies, AlphaScreen ubiquitin assays enable measurement of DUB activity toward more physiologically relevant ubiquitinated protein substrates and are valuable for validating inhibitor selectivity in a substrate-specific context.
Substrate: Ub-AMC
Ex/Em (nm): 350/440
Signal Type: Fluorescence increase
HTS Suitability: Moderate
Compound Interference: High (UV range)
Key Advantage: Low cost, well validated
Substrate: Ub-Rho110
Ex/Em (nm): 496/520
Signal Type: Fluorescence increase
HTS Suitability: Excellent
Compound Interference: Low
Key Advantage: High signal/noise, broad DUB activity
Substrate: Ub-TAMRA
Ex/Em (nm): 541/568
Signal Type: Fluorescence increase / FP
HTS Suitability: Good
Compound Interference: Moderate
Key Advantage: FP/FA assays, multiplexing
Substrate:
Ex/Em (nm): Various (TR-FRET)
Signal Type: FRET ratio change
HTS Suitability: Excellent
Compound Interference: Very low
Key Advantage: Compound autofluorescence rejection
Substrate: AlphaScreen
Ex/Em (nm): 680→615 nm
Signal Type: Luminescence decrease
HTS Suitability: Good
Compound Interference: Low
Key Advantage: Physiological substrate context
5. Diubiquitin and Polyubiquitin Probes
5.1 Rationale for Linkage-Selective Probes
A fundamental limitation of C-terminal ubiquitin probes (Ub-VS, Ub-Rho110, Ub-AMC) is that they report only on the ability of an enzyme to cleave the C-terminal extension of a single ubiquitin molecule, without recapitulating the chain linkage context that defines the natural substrates of many DUBs. In vivo, DUBs often display exquisite selectivity for particular ubiquitin chain linkage types (e.g., OTULIN cleaves only M1-linked chains, OTUD3 prefers K6, TRABID prefers K29/K33, AMSH prefers K63). To study and exploit this selectivity, probes based on defined diubiquitin or polyubiquitin chains have been developed.
5.2 Diubiquitin ABPs
Diubiquitin activity-based probes consist of two ubiquitin units linked in a defined topology (K6, K11, K27, K29, K33, K48, K63, or M1), with a reactive warhead installed at the C-terminus of the distal ubiquitin. These probes are recognized by linkage-selective DUBs in a manner that mimics the natural polyubiquitin substrate, enabling selective labeling of chain-specific DUBs in complex proteomes. Diubiquitin ABPs have been produced by a combination of recombinant protein expression, intein-mediated protein ligation, sortase-mediated transpeptidation, and chemical protein synthesis, reflecting the significant synthetic challenge of producing defined ubiquitin chain topologies at scale.
Diubiquitin ABPs with VS or PA warheads have been used to selectively profile K48-selective DUBs (e.g., OTUD2, USP14, UCHL5 within the proteasome), K63-selective DUBs (e.g., AMSH, AMSH-LP, USP3, BRCC36), and M1-selective DUBs (e.g., OTULIN, LUBAC-associated DUBs). Comparison of diubiquitin and monoubiquitin ABP labeling profiles reveals linkage-selectivity that would be invisible using C-terminal probes alone.
5.3 Diubiquitin Fluorogenic Substrates
Fluorogenic diubiquitin substrates incorporate Rhodamine 110 or AMC at the C-terminus of the distal ubiquitin within defined chain topologies. These substrates enable kinetic characterization of linkage-selective DUBs using standard fluorescence-based assays, combining the selectivity of diubiquitin chain context with the sensitivity of the fluorogenic readout. Production is more complex and costly than monoubiquitin fluorogenic substrates, but commercial sources for several key linkages (M1, K48, K63) are now available.
5.4 Ubiquitin-FRET Probes (Internally Quenched)
Internally quenched FRET probes consisting of two ubiquitin units — one bearing a fluorescent donor (e.g., fluorescein) and one bearing a quenching acceptor (e.g., tetramethylrhodamine or QSY dyes) — linked through a defined isopeptide bond have been developed. In the intact probe, FRET from donor to acceptor quenches donor fluorescence. DUB-mediated chain cleavage separates the donor and acceptor, restoring donor fluorescence. These probes are particularly powerful for studying processivity and mode of cleavage (exo- vs. endo-chain cleavage) by DUBs.
6. Ubiquitin Affinity and Enrichment Probes
6.1 Tandem Ubiquitin-Binding Entity (TUBE) Technology
Tandem ubiquitin-binding entities (TUBEs) are synthetic reagents consisting of multiple ubiquitin-binding domain (UBD) units in tandem, typically four or more UBDs connected by flexible linkers. The avidity effect of multiple UBDs acting cooperatively enables TUBEs to bind polyubiquitin chains with nanomolar affinity, orders of magnitude higher than individual UBDs. TUBEs have been widely used as affinity reagents to enrich ubiquitinated proteins from cell lysates for subsequent identification by mass spectrometry or immunoblotting. They also protect ubiquitinated proteins from DUB-mediated deubiquitination during sample preparation, a significant advantage over conventional approaches.
Several TUBE variants have been developed with different UBD compositions to target specific linkage types. TUBE1 (based on UBA domains) shows preference for K48-linked chains, while TUBE2 shows broader selectivity. Linkage-selective TUBEs incorporating UBDs from proteins such as RAP80 (K63-selective) or NEMO (M1-selective) have been generated to enrich specific chain-type-modified proteomes.
6.2 Ubiquitin-Biotin Affinity Probes
Biotinylated ubiquitin variants are used for affinity pull-down of ubiquitin-interacting proteins (UBDs, DUBs, E3 ligases) from cell lysates. When expressed in cells, biotinylated ubiquitin (achieved through genetic code expansion with biotinylated lysine analogs or enzymatic biotinylation of Avi-tagged ubiquitin) incorporates into the ubiquitin pathway and labels ubiquitinated proteins in a physiologically relevant manner. Subsequent streptavidin-based enrichment enables mass spectrometry-based identification of the ubiquitinated proteome.
6.3 Ubiquitin Remnant Profiling (diGly Enrichment)
When ubiquitinated proteins are digested with trypsin, the isopeptide-linked ubiquitin leaves a characteristic diglycine remnant (di-Gly, GG) on the modified lysine. Antibodies raised against the diGly-lysine modification enable immunoaffinity enrichment of diGly-containing peptides from tryptic digests, enabling proteome-wide mapping of ubiquitination sites by mass spectrometry. This approach, sometimes called “ubiquitin remnant profiling” or “Ub-AQUA,” has been used to identify tens of thousands of ubiquitination sites in human cells and has become a cornerstone of quantitative ubiquitin proteomics. Anti-diGly antibodies are commercially available (e.g., from Cell Signaling Technology, PTMScan platform) and are widely used in the field.
7. Crosslinking and Photo-Activatable Ubiquitin Probes
7.1 Chemical Crosslinking Probes
Crosslinking ubiquitin probes incorporate bifunctional crosslinkers that form covalent bonds between ubiquitin and its interacting partners. These probes are designed to capture transient or low-affinity interactions that would be lost during conventional pull-down experiments. The crosslinker is typically installed at specific positions on the ubiquitin surface, guided by structural data on ubiquitin-protein interfaces, enabling site-directed crosslinking toward interacting partners.
Common crosslinker chemistries used in ubiquitin probe applications include NHS ester-amine crosslinking, thiol-reactive maleimide crosslinking (using strategically positioned cysteine mutations in ubiquitin), and disuccinimidyl crosslinkers. After crosslinking and enrichment, interacting proteins are identified by mass spectrometry and the crosslinked interface is mapped by tandem MS analysis of crosslinked peptide pairs.
7.2 Photo-Activatable Ubiquitin Probes
Photo-activatable ubiquitin probes incorporate diazirine or benzophenone photoreactive groups at specific positions within the ubiquitin sequence or at the C-terminus. Upon UV irradiation (typically 350–365 nm for diazirines, 365 nm for benzophenones), these groups generate highly reactive nitrene or diradical species that crosslink to nearby amino acids on interacting proteins in a distance-dependent manner (≤3.5 Å for diazirines, <3 nm for benzophenones). The resulting covalent adducts are stable to denaturing conditions, enabling stringent purification and mass spectrometry-based identification of crosslinked partners.
Photo-activatable ubiquitin probes have been used to map the binding interfaces of DUBs, E3 ligases, and ubiquitin readers on the ubiquitin surface. By incorporating the photoreactive group at different positions (L8, R42, K48, K63, etc.), different regions of the ubiquitin surface can be probed for interaction with partner proteins. This approach has provided structural insights into ubiquitin-protein interactions that complement crystallographic and NMR studies.
7.3 Disulfide-Directed Crosslinking Probes
A specialized subset of crosslinking probes uses strategically positioned disulfide bonds to crosslink ubiquitin to interacting DUBs. When a cysteine is introduced near the C-terminus of ubiquitin (e.g., at position 75 or as a C-terminal extension), the resulting thiol can form a disulfide bond with the active-site cysteine of a DUB, trapping the enzyme-substrate complex at the pre-cleavage stage. This approach has been used to obtain structures of DUB-ubiquitin complexes by X-ray crystallography and cryo-EM, providing critical mechanistic insights into DUB catalysis.
8. Engineered Ubiquitin Variants and Protein-Based Probes
8.1 Ubiquitin Variants (UbVs)
Ubiquitin variants (UbVs) are engineered ubiquitin proteins with mutations in the binding interface that confer highly selective, tight binding to specific DUBs or ubiquitin-binding domain proteins. UbVs are typically identified through phage display or yeast surface display selection campaigns against target proteins using diversified ubiquitin libraries. By randomizing residues on the ubiquitin binding surface (L8, I44, H68, V70 hydrophobic patch; K6, K11, K27, K33, K48, K63 regions; etc.), variants with sub-nanomolar affinity and exquisite selectivity for individual DUBs can be identified.
UbVs serve as powerful selective inhibitors of DUBs for cell biology experiments (when delivered intracellularly), as structural tools to capture DUB-ubiquitin complexes for crystallography, and as affinity reagents for DUB pulldown and characterization. When the reactive Gly76 C-terminus of a UbV is modified with an electrophilic warhead, the resulting activity-based UbV probe combines the selectivity of the engineered binding surface with the covalent reactivity of the ABP warhead, potentially enabling selective labeling of a single DUB from complex proteomes.
8.2 Ubiquitin-Based Inhibitors (Ubiquitin Fusions)
Genetic fusion of ubiquitin to interacting proteins (or expression of ubiquitin fused to peptide inhibitors of DUBs) has been used as a protein-based probe strategy. Linear ubiquitin-protein fusions are rapidly cleaved by DUBs in cells, but when designed with C-terminal warheads or when the cleavage site is blocked, they can serve as sustained inhibitors or activity reporters in cellular contexts.
8.3 Nanobody and Affimer-Based Ubiquitin Probes
Single-domain antibodies (nanobodies) derived from camelid antibodies and synthetic binding proteins (Affimers, DARPins) have been engineered to bind ubiquitin or specific ubiquitinated epitopes with high affinity and selectivity. These protein-based reagents are used as detection tools in immunofluorescence, flow cytometry, and proximity ligation assays to visualize ubiquitination in cells and tissues. Anti-ubiquitin nanobodies with high selectivity for K48- or K63-linked chains have been developed for chain-specific detection applications.
9. Isotope-Labeled Ubiquitin Probes for Quantitative Proteomics and NMR
9.1 SILAC and TMT-Based Ubiquitin Proteomics
Stable isotope labeling by amino acids in cell culture (SILAC) combined with diGly remnant enrichment enables quantitative measurement of ubiquitination site dynamics in response to cellular perturbations. Cells grown in heavy isotope-labeled amino acids (¹³C6-lysine, ¹³C6-arginine) generate heavy ubiquitinated peptides that can be distinguished from light (unlabeled) peptides by mass spectrometry. Tandem mass tag (TMT) and iTRAQ isobaric labeling strategies extend this to multiplexed comparisons of up to 18 conditions simultaneously. These approaches have been used to map ubiquitinome changes during proteasome inhibition, viral infection, DNA damage, and in response to DUB knockdown or inhibitor treatment.
9.2 ¹³C/¹⁵N-Labeled Ubiquitin for NMR
Uniformly ¹³C- and ¹⁵N-labeled recombinant ubiquitin is produced by expression in E. coli cultured in isotope-enriched minimal media (¹³C-glucose, ¹⁵N-ammonium chloride). These isotope-labeled ubiquitin preparations are essential for NMR-based structural studies of ubiquitin-protein interactions, as they enable complete resonance assignment and precise mapping of binding interfaces through chemical shift perturbation (CSP) experiments. Segmentally labeled ubiquitin — in which only one unit of a diubiquitin chain is labeled — has been used to solve the solution structures of polyubiquitin chains and to study their conformational dynamics.
9.3 ²H-Labeled Ubiquitin for Solution NMR
Deuterium (²H) labeling of ubiquitin, often combined with ¹³C/¹⁵N labeling (triple labeling), reduces dipolar relaxation and enables TROSY-based NMR experiments on larger ubiquitin complexes and polyubiquitin chains that would be inaccessible to conventional NMR due to slow tumbling. Perdeuterated ubiquitin has been used to study the structure and dynamics of K48-linked diubiquitin (a compact, closed conformation in solution) and K63-linked diubiquitin (an extended, open conformation), providing fundamental insights into how chain topology encodes biological function.
10. Applications in Drug Discovery
10.1 DUB Inhibitor Discovery
DUBs are among the most actively pursued therapeutic targets in the ubiquitin field. Dysregulation of DUB activity has been implicated in cancer, neurodegeneration, viral infection, inflammatory disease, and other pathologies. Ubiquitin probes have been central to every stage of the DUB inhibitor discovery pipeline:
• Target validation: ABPs and fluorogenic substrates confirm that a DUB of interest is active and druggable in the relevant biological context.
• Assay development: Ub-Rho110 and FRET substrates form the basis of biochemical assays for HTS campaigns against DUB targets.
• Hit identification: HTS using fluorogenic substrates has identified multiple DUB inhibitor chemotypes now in advanced preclinical development.
• Selectivity profiling: Competitive ABPP using Ub-VS or Ub-PA probes enables proteome-wide selectivity profiling of DUB inhibitor candidates, identifying off-target DUBs and guiding medicinal chemistry optimization.
• Mechanism of action: Gel-based competitive ABPP confirms target engagement and determines whether an inhibitor is covalent or non-covalent.
• Pharmacodynamic (PD) biomarker development: ABP-based target occupancy assays in cell lysates or tissue biopsies monitor DUB inhibition in vivo and support clinical dosing decisions.
10.2 E3 Ligase-Targeted Drug Discovery
While probes for E3 ubiquitin ligases are less developed than DUB probes, significant progress has been made. Ubiquitin-vinyl methyl ester (Ub-VME) probes react preferentially with the active-site cysteine of HECT and RBR family E3 ligases, enabling their selective profiling. Substrate trap approaches using catalytically inactive E3 ligase mutants and biotinylated ubiquitin have been used to identify E3 substrates. The explosion of interest in targeted protein degradation (PROTAC and molecular glue strategies) has further motivated the development of E3 ligase activity probes for characterizing the activity and substrate scope of recruited E3s (CRBN, VHL, MDM2, IAP family, etc.).
10.3 Proteasome Activity Monitoring
The 26S proteasome is the terminal effector of K48-linked polyubiquitin-targeted protein degradation. Ubiquitin probes are used alongside proteasome activity probes (e.g., MVB072, MV151) to simultaneously monitor DUB activity and proteasome activity in the same sample, providing a comprehensive picture of UPS flux. Ub-Rho110 and Ub-AMC fluorescent substrates are frequently employed alongside proteasome fluorogenic peptide substrates (Suc-LLVY-AMC, Z-LLE-AMC, Boc-LRR-AMC) in parallel assays to dissect the UPS at multiple levels.
10.4 Deubiquitylase Selectivity Profiling by Competitive ABPP
Competitive ABPP is a powerful strategy for determining the selectivity of DUB inhibitors across the entire expressed DUBome. In this approach, proteomes are treated with a DUB inhibitor at varying concentrations before addition of a broadly reactive DUB ABP (Ub-VS or Ub-PA). The inhibitor competes with the ABP for the DUB active site; DUBs engaged by the inhibitor are not labeled by the ABP, while uninhibited DUBs are labeled. After enrichment (for biotinylated ABPs) and quantitative mass spectrometry analysis (iTRAQ, TMT, or label-free quantification), dose-dependent competition at each DUB in the proteome is measured, yielding a selectivity profile across the expressed DUBome in a single experiment.
11. Applications in Cell Biology and Structural Biology
11.1 Visualization of Ubiquitination in Cells
Fluorescently labeled ubiquitin (GFP-ubiquitin, mCherry-ubiquitin) has been used for decades to visualize ubiquitin distribution and dynamics in living cells by fluorescence microscopy. These fusion proteins incorporate into the ubiquitin pathway and label ubiquitinated proteins and ubiquitin-positive organelles (autophagosomes, aggresomes, ubiquitin-positive nuclear bodies). More recently, ubiquitin sensors based on UBD fusions to fluorescent proteins (e.g., tandem UBA-GFP sensors) have been developed to report on polyubiquitin chain accumulation at specific subcellular locations in real time.
For higher resolution and specificity, proximity ligation assays (PLA) using anti-ubiquitin and anti-target protein antibodies enable visualization of ubiquitinated forms of specific proteins in fixed cells with single-molecule sensitivity. Anti-chain-selective nanobodies fused to fluorescent proteins are emerging as tools for live-cell imaging of specific chain types.
11.2 DUB Active-Site Mapping and Structural Studies
Disulfide crosslinking and Michael acceptor warhead ABPs have been used to prepare DUB-ubiquitin covalent complexes for X-ray crystallography and cryo-electron microscopy. Structures of DUBs in complex with Ub-VS or Ub-PA conjugates have provided detailed insights into catalytic mechanisms, ubiquitin recognition determinants, and the structural basis of DUB regulation. Landmark structures obtained using ubiquitin ABPs include those of USP7, USP14, UCH-L1, UCH-L3, OTUB1, OTUB2, OTULIN, AMSH-LP, and many others, fundamentally advancing understanding of DUB biology.
11.3 Ubiquitin Chain Structure and Dynamics by NMR
Isotopically labeled diubiquitin probes have been instrumental in NMR studies of polyubiquitin chain conformation. K48-linked diubiquitin adopts a compact, closed conformation in solution where the hydrophobic patches of both ubiquitin units are buried at the interdomain interface. K63-linked diubiquitin, by contrast, adopts an extended, open conformation with exposed hydrophobic patches on each unit. These distinct conformations are thought to underlie the differential recognition of K48 vs. K63 chains by readers and DUBs. M1-linked diubiquitin adopts yet another conformation, reflecting the structural diversity encoded in the ubiquitin code.
12. Limitations and Technical Considerations
12.1 Probe Selectivity and Cross-Reactivity
Broadly reactive DUB ABPs such as Ub-VS and Ub-PA label most or all active cysteine DUBs in a proteome, which is advantageous for unbiased profiling but limits their utility for studying individual DUBs in complex mixtures. Selectivity for specific DUBs requires the use of engineered ubiquitin variants, linkage-selective diubiquitin probes, or cell-based experiments where specific DUBs can be genetically manipulated.
12.2 Requirement for Enzyme Activation
All cysteine DUBs require the active-site cysteine to be in the reduced, nucleophilic state for ABP labeling. In cell lysates, oxidative conditions or the presence of alkylating agents (NEM, iodoacetamide) can inactivate DUBs before probe addition. Standard protocols include freshly prepared reducing agents (DTT, TCEP) and careful handling to minimize oxidative artifacts. Over-reduction can also be problematic if it reduces disulfide bonds important for protein structure.
12.3 Cell Permeability
As discussed, the large size and hydrophilic surface of ubiquitin-based probes severely limits their membrane permeability. Most ABPP experiments using ubiquitin probes are performed in cell lysates rather than intact cells, which may not fully reflect the physiological state of DUBs in the intact cellular environment. Cell permeability remains a major unmet technical challenge in the ubiquitin probe field.
12.4 Stoichiometric Probe Requirements
ABPs are consumed stoichiometrically as they covalently label their targets. In complex proteomes containing many DUBs at varying concentrations, probe depletion can be an issue at low probe concentrations. Optimal probe concentrations must be determined empirically for each proteome and experimental context to ensure complete labeling of low-abundance DUBs without masking higher-abundance ones.
12.5 Compound Interference in Fluorogenic Assays
Fluorescence-based DUB substrates (particularly UV-range substrates like Ub-AMC) are susceptible to interference from fluorescent compounds in screening libraries. Appropriate counter-screens, assay controls, and orthogonal validation approaches (gel-based, MS-based) are essential to avoid false positives in HTS campaigns.
12.6 Biological Complexity of Lysate-Based Assays
When ubiquitin probes are used in cell or tissue lysates, the observed signal reflects the aggregate activity of all active ubiquitin-processing enzymes in the sample. Dissecting the contribution of individual enzymes requires complementary approaches such as immunodepletion, genetic knockdown, or the use of selective inhibitors.
13. Emerging Frontiers
13.1 In-Cell and In Vivo ABPP
Development of cell-permeable ubiquitin ABPs remains an active and challenging area. Approaches under investigation include minimal ubiquitin mimetics (short peptides carrying C-terminal warheads that engage the DUB active site), lipidated or CPP-fused probes, and nanobody-warhead conjugates directed against DUB surface epitopes. In vivo ABPP in animal models, which would enable DUB activity profiling in whole organisms, represents a frontier with profound implications for target validation and pharmacodynamic monitoring in therapeutic programs.
13.2 Branched and Atypical Chain Probes
Branched ubiquitin chains — in which a single ubiquitin carries modifications at two different lysines simultaneously — have emerged as important signaling entities in immune activation and mitophagy. Probes incorporating branched chain topologies are being developed to study the DUBs and readers that specifically recognize these complex modifications. Similarly, probes for atypical serine- and threonine-linked ubiquitination (as employed by bacterial effector proteins) are an emerging area of chemical biology.
13.3 Proximity Labeling Approaches
Proximity labeling enzymes (BioID, TurboID, APEX2) fused to ubiquitin or ubiquitin-binding domains are being used to capture the local proteome surrounding ubiquitinated proteins or ubiquitin-processing enzymes in living cells. These approaches complement traditional affinity enrichment by capturing weak or transient interactions that are missed by conventional pull-downs. Combining proximity labeling with site-specific ubiquitin probes offers the potential to map the spatial organization of the ubiquitin pathway within specific organelles or macromolecular complexes.
13.4 Single-Molecule and Super-Resolution Imaging
Fluorescently labeled ubiquitin probes and anti-chain nanobodies are being adapted for single-molecule TIRF microscopy and super-resolution fluorescence imaging (STORM, PALM, STED) to visualize individual ubiquitination events and ubiquitin chain accumulation at specific subcellular structures. These approaches are providing new insights into the spatial regulation of ubiquitin signaling at a level of resolution not achievable with conventional fluorescence microscopy.
13.5 Artificial Intelligence and Probe Design
Machine learning approaches are increasingly being applied to predict DUB-ubiquitin binding interfaces, optimize ubiquitin variant sequences for selectivity, and prioritize warhead-recognition element combinations for ABP development. AlphaFold2-based structural predictions of DUB-ubiquitin complexes are accelerating rational probe design by providing three-dimensional models of enzyme-substrate interactions that can guide the placement of warheads and reporter tags.
13.6 Probes for Ubiquitin-Like Modifiers (UBLs)
Analogous probe chemistries have been applied to ubiquitin-like modifiers including NEDD8, SUMO1/2/3, ISG15, FAT10, UFM1, URM1, and others. NEDD8-VS and NEDD8-PA probes label neddylation-processing enzymes (CSN5, NEDP1, DEN1), SUMO-VS probes label SUMO proteases (SENPs), and ISG15-VS probes label USP18 and other ISG15 deconjugases. The parallel development of UBL probe toolkits is enabling systematic comparison of UBL pathway enzymes and is uncovering unexpected cross-reactivity between ubiquitin and UBL processing enzymes.
14. Summary and Conclusions
Ubiquitin probes have emerged as indispensable tools for the study of the ubiquitin-proteasome system, deubiquitylating enzymes, E3 ubiquitin ligases, and ubiquitin reader proteins. From the earliest fluorogenic substrates (Ub-AMC) to sophisticated diubiquitin ABPs, engineered ubiquitin variants, and emerging cell-permeable probe technologies, the ubiquitin probe toolkit has grown enormously in scope and sophistication over the past three decades.
The impact of ubiquitin probes on fundamental biology has been transformative: they have enabled the discovery and characterization of entire DUB enzyme families, revealed the structural basis of ubiquitin recognition and chain selectivity, provided proteome-wide maps of ubiquitination dynamics, and uncovered the connections between ubiquitin pathway dysregulation and human disease. In the drug discovery arena, ubiquitin probes have been central to the identification and development of DUB inhibitors, E3 ligase modulators, and the validation of PROTACs and molecular glues as targeted protein degradation modalities.
Despite remarkable progress, significant challenges remain. Cell permeability of protein-based probes, development of probes for all ubiquitin chain linkages, translation of biochemical ABPP findings to in vivo contexts, and the development of probes for E1 and E2 enzymes are among the most important unmet needs. Emerging technologies including genetic code expansion, proximity labeling, super-resolution imaging, and AI-guided probe design are poised to accelerate progress in these areas.
As the therapeutic relevance of the ubiquitin pathway continues to expand — spanning oncology, neurodegeneration, immunity, virology, and targeted protein degradation — demand for ever more sophisticated, selective, and versatile ubiquitin probes will continue to grow. The field stands at an exciting juncture, with the foundational probe toolkit in place and the next generation of innovations on the horizon.
References
1. Borodovsky A, Ovaa H, Kolli N, et al. Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem Biol. 2002;9(10):1149–1159.
2. Ovaa H. Active-site directed probes of the ubiquitin and ubiquitin-like modification pathways. Nat Rev Cancer. 2007;7(8):613–620.
3. Komander D, Clague MJ, Urbé S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009;10(8):550–563.
4. Ye Y, Rape M. Building ubiquitin chains: E2 enzymes at work. Nat Rev Mol Cell Biol. 2009;10(11):755–764.
5. Kim W, Bennett EJ, Huttlin EL, et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011;44(2):325–340.
6. Harrigan JA, Jacq X, Martin NM, Jackson SP. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov. 2018;17(1):57–78.
7. Mevissen TET, Komander D. Mechanisms of deubiquitinase specificity and regulation. Annu Rev Biochem. 2017;86:159–192.
8. Clague MJ, Urbé S, Komander D. Breaking the chains: deubiquitylating enzyme specificity begets function. Nat Rev Mol Cell Biol. 2019;20(6):338–352.
9. Abdul Rehman SA, Kristariyanto YA, Choi SY, et al. MINDY-1 is a member of an evolutionarily conserved and structurally distinct new family of deubiquitinating enzymes. Mol Cell. 2016;63(1):146–155.
10. Hermanns T, Pichler P, Lux K, et al. An evolutionary approach reveals a propensity for DUB activity in UBL domain-containing proteins. Biochem J. 2020;477(19):3799–3820.
11. Mulder MP, Witting K, Berlin I, et al. A cascading activity-based probe sequentially targets E1-E2-E3 enzymes of the ubiquitin cascade. Nat Chem Biol. 2016;12(7):523–530.
12. Ritorto MS, Ewan R, Perez-Oliva AB, et al. Screening of DUB activity and specificity by MALDI-TOF mass spectrometry. Nat Commun. 2014;5:4763.
13. Wertz IE, Murray JM. Structurally-defined deubiquitinase inhibitors provide opportunities to investigate disease mechanisms. Drug Discov Today Technol. 2019;31:109–123.
14. Keuss MJ, Hjerpe R, Hsia O, et al. Unanchored tri-NEDD8 inhibits PARP-1 to protect from oxidative stress-induced cell death. EMBO J. 2019;38(12):e100024.
15. Schauer NJ, Liu X, Magin RS, et al. Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism. Sci Rep. 2020;10:5324.
